Skip to content

Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities

Colorectal Cancer Screening in Black and Underserved Communities in the Phoenix Metro Area: Addressing Disparities in Cancer Prevention

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05447923
Enrollment
450
Registered
2022-07-07
Start date
2022-05-22
Completion date
2030-06-01
Last updated
2026-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Carcinoma

Brief summary

This clinical trial studies disparities involving colorectal cancer prevention and screening in Black and underserved communities in the Phoenix metropolitan area. The Black community is disproportionately impacted by colorectal cancer, with the highest rate of any racial/ethnic group in the United States. There are complex reasons behind these disparities, largely related to socioeconomic factors and healthcare access. Providing access to free, home-based fecal immunochemical testing (FIT), colorectal screening education, and appropriate follow-up to predominantly Black community-based organizations and underserved communities may help to close this gap.

Detailed description

PRIMARY OBJECTIVES: I. To evaluate patient navigation to address colorectal cancer disparities seen in people of color, minority populations, and establish an ongoing colorectal cancer screening outreach program for this community in Phoenix. OUTLINE: Participants receive free FIT tests in conjunction with education on colorectal cancer screening. Participants undergo self-collect FIT and mail the sample to Mayo Clinic Lab for processing. Participants also complete a questionnaire about colorectal cancer screening and healthcare. Participants receive FIT test results through Mayo Clinic nursing support and participants with a positive test are followed up by a patient navigator to discuss next steps and consultation with a gastroenterologist to review their results. After completion of screening, participants with a positive FIT test are followed up at 2 and 4 weeks after initial outreach to assure participants have received adequate follow up.

Interventions

OTHEREducational Intervention

Undergo education for colorectal cancer screening

Undergo FIT testing

BEHAVIORALPatient Navigation

Undergo patient navigation for positive FIT results

OTHERQuestionnaire Administration

Complete questionnaire about colorectal cancer screening and healthcare

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 45 years of age or older * No prior history of colorectal cancer or colon polyps * No first-degree family history of colorectal cancer who were diagnosed under age 60 * No current gastrointestinal (GI) or rectal symptoms (such as rectal bleeding) * Have not undergone a colonoscopy in the last 5 years * Have not had a fecal immunochemical test (FIT) test within the last year * Participants that attend 4 predominantly African American churches within the Phoenix Community and extend the study opportunity as feasible to other underserved communities in the Phoenix Metro area

Design outcomes

Primary

MeasureTime frameDescription
Colorectal cancer disparities seen in people of color and minority populationsUp to study completion, up to 30 daysEvaluate patient navigation to address colorectal cancer disparities seen in people of color, minority populations, and establish an ongoing colorectal cancer screening outreach program.

Countries

United States

Contacts

CONTACTYahaira J. Parker
Parker.Yahaira@mayo.edu480-574-3171
CONTACTClinical Trials Referral Office
mayocliniccancerstudies@mayo.edu855-776-0015
PRINCIPAL_INVESTIGATORJuliana M. Kling, MD, MPH

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026